News
By John Vandermosten, CFA NYSE:CVM READ THE FULL CVM RESEARCH REPORT First Quarter Fiscal Year 2023 Update CEL-SCI Corporation (NYSE:CVM) reported first quarter fiscal year 2023 results on ...
By John Vandermosten, CFA NYSE:CVM READ THE FULL CVM RESEARCH REPORT Multikine Clinical Data CEL-SCI Corporation (NYSE:CVM) has continued to generate data and analysis related to its IT-MATTERS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback